BM
Meyer, Benjamin
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA–peptide conjugates | Proceedings of the National Academy of Sciences of the United States of America | 2025 | 71 | 73 | |||
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | 2024 | 66 | 80 | |||
| SARS-CoV-2 viral load and shedding kinetics | Nature reviews. Microbiology | 2023 | 209 | 102 | |||
| Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus | PloS one | 2023 | 103 | 41 | |||
| SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses | EBioMedicine | 2023 | 112 | 173 | |||
| Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | 2023 | 199 | 42 | |||
| Influence of circadian clocks on adaptive immunity and vaccination responses | Nature communications | 2023 | 305 | 73 | |||
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 167 | 147 | |||
| Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva | Epidemics | 2022 | 193 | 94 | |||
| Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | 2022 | 114 | 45 | |||
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 84 | 0 | |||
| Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | 2022 | 1,447 | 201 | |||
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 437 | 125 | |||
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 150 | 115 | |||
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | 2022 | 282 | 153 | |||
| Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine | 2022 | 274 | 149 | |||
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 195 | 132 | |||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | 2021 | 436 | 187 | |||
| SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 372 | 38 | |||
| Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | 2021 | 433 | 235 | |||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 520 | 305 | |||
| Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | 2021 | 306 | 126 | |||
| Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort study | Infection Control and Hospital Epidemiology | 2021 | 312 | 186 | |||
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | 2021 | 299 | 254 | |||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 403 | 198 | |||
| Waning antibodies to SARS-CoV-2 - Don't panic | The Lancet Regional Health. Europe | 2021 | 172 | 70 | |||
| Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana | One Health Outlook | 2021 | 254 | 98 | |||
| SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | 2021 | 407 | 244 | |||
| A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | 2021 | 344 | 216 | |||
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | 2021 | 637 | 145 | |||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 338 | 168 | |||
| Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT) | Emerging Microbes & Infections | 2020 | 457 | 198 | |||
| Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | 2020 | 512 | 289 | |||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet | 2020 | 772 | 14 | |||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 453 | 385 | |||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 376 | 190 | |||
| SARS-CoV-2 seroprevalence in COVID-19 hotspots | The Lancet | 2020 | 348 | 102 | |||
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 517 | 195 | |||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | 2020 | 266 | 103 | |||
| Link of a ubiquitous human coronavirus to dromedary camels | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 226 | 123 |
